Another group of antidepressant are dual NET/DAT inhibitors (e.g., nomifensin), while triple reuptake inhibitors (SERT/DAT/NET inhibitors, e.g., indatraline and mazindol) are being examined for their efficacy in depression and other CNS-disorders [158]. The gene discussed is SLC6A3; the disease is depressive disorder.